Matches in Wikidata for { <http://www.wikidata.org/entity/Q94147703> ?p ?o ?g. }
- Q94147703 description "2018 nî lūn-bûn" @default.
- Q94147703 description "2018 թվականի նոյեմբերի 5-ին հրատարակված գիտական հոդված" @default.
- Q94147703 description "2018年の論文" @default.
- Q94147703 description "2018年学术文章" @default.
- Q94147703 description "2018年学术文章" @default.
- Q94147703 description "2018年学术文章" @default.
- Q94147703 description "2018年学术文章" @default.
- Q94147703 description "2018年学术文章" @default.
- Q94147703 description "2018年学术文章" @default.
- Q94147703 description "2018年學術文章" @default.
- Q94147703 description "2018年學術文章" @default.
- Q94147703 description "2018年學術文章" @default.
- Q94147703 description "2018年學術文章" @default.
- Q94147703 description "2018年學術文章" @default.
- Q94147703 description "2018년 논문" @default.
- Q94147703 description "article científic" @default.
- Q94147703 description "article scientific" @default.
- Q94147703 description "article scientifique" @default.
- Q94147703 description "articol științific" @default.
- Q94147703 description "articolo scientifico" @default.
- Q94147703 description "artigo científico" @default.
- Q94147703 description "artigo científico" @default.
- Q94147703 description "artigo científico" @default.
- Q94147703 description "artikel ilmiah" @default.
- Q94147703 description "artikull shkencor" @default.
- Q94147703 description "artikulong pang-agham" @default.
- Q94147703 description "artykuł naukowy" @default.
- Q94147703 description "artículo científico publicado en 2018" @default.
- Q94147703 description "artículu científicu" @default.
- Q94147703 description "bilimsel makale" @default.
- Q94147703 description "bài báo khoa học" @default.
- Q94147703 description "naučni članak" @default.
- Q94147703 description "scienca artikolo" @default.
- Q94147703 description "scientific article published on 5 November 2018" @default.
- Q94147703 description "scientific article published on 5 November 2018" @default.
- Q94147703 description "scientific article published on 5 November 2018" @default.
- Q94147703 description "teaduslik artikkel" @default.
- Q94147703 description "tieteellinen artikkeli" @default.
- Q94147703 description "tudományos cikk" @default.
- Q94147703 description "vedecký článok" @default.
- Q94147703 description "vetenskaplig artikel" @default.
- Q94147703 description "videnskabelig artikel udgivet 5. november 2018" @default.
- Q94147703 description "vitenskapelig artikkel" @default.
- Q94147703 description "vitskapeleg artikkel" @default.
- Q94147703 description "vědecký článek" @default.
- Q94147703 description "wetenschappelijk artikel" @default.
- Q94147703 description "wissenschaftlicher Artikel" @default.
- Q94147703 description "επιστημονικό άρθρο" @default.
- Q94147703 description "мақолаи илмӣ" @default.
- Q94147703 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q94147703 description "научна статия" @default.
- Q94147703 description "научная статья" @default.
- Q94147703 description "научни чланак" @default.
- Q94147703 description "научни чланак" @default.
- Q94147703 description "מאמר מדעי" @default.
- Q94147703 description "مقالة علمية نشرت في 5 نوفمبر 2018" @default.
- Q94147703 description "৫ নভেম্বর ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q94147703 description "บทความทางวิทยาศาสตร์" @default.
- Q94147703 description "სამეცნიერო სტატია" @default.
- Q94147703 name "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 name "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 type Item @default.
- Q94147703 label "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 label "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 prefLabel "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 prefLabel "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 P1433 Q94147703-E8A1BE28-F3C1-4BF9-9FD6-2CBD39095E86 @default.
- Q94147703 P1476 Q94147703-60CA9B4E-F3AD-4288-9A74-18DFD750041D @default.
- Q94147703 P2093 Q94147703-0C7922C7-752F-4520-8387-7093129D5D93 @default.
- Q94147703 P2093 Q94147703-1F4F8122-11A3-4722-ABFF-1940335DEECD @default.
- Q94147703 P2093 Q94147703-37B05B31-C413-4965-9DE7-032D3FC73A05 @default.
- Q94147703 P2093 Q94147703-43110BD3-466B-4151-91CB-4FEB34615D22 @default.
- Q94147703 P2093 Q94147703-43135A08-8201-4B05-B1ED-DCA50F007399 @default.
- Q94147703 P2093 Q94147703-49546834-0F8B-4E27-9EDE-54CF014ED01A @default.
- Q94147703 P2093 Q94147703-4A5A7AB6-CC92-4341-98C3-9E48DC883E3A @default.
- Q94147703 P2093 Q94147703-4F28E982-40DA-4DF4-BC53-CCE8A6978FF5 @default.
- Q94147703 P2093 Q94147703-6387F2CE-6AEA-4366-AAC5-0B7F51A7C6BF @default.
- Q94147703 P2093 Q94147703-687877B4-D76D-4716-A0F2-BEFD10481F56 @default.
- Q94147703 P2093 Q94147703-737A40E2-9132-4B4D-8992-D91311C03E25 @default.
- Q94147703 P2093 Q94147703-95F5B6A9-B175-4D38-A087-914D4621F3D2 @default.
- Q94147703 P2093 Q94147703-C7EF98C5-89A4-4C87-B163-1944539BB901 @default.
- Q94147703 P2093 Q94147703-CE2E3154-4285-479D-AF7C-4EB237BDBEDF @default.
- Q94147703 P2093 Q94147703-D84B29CF-7495-4B3F-962B-0D97C78575BB @default.
- Q94147703 P2093 Q94147703-DD795419-91FF-42F8-AA12-C70E103B1360 @default.
- Q94147703 P2093 Q94147703-F0BFFDC8-A4E9-462C-86E6-5A00807E49C8 @default.
- Q94147703 P304 Q94147703-8459D49D-8CCB-4891-94E7-9D2D2C7CB67E @default.
- Q94147703 P31 Q94147703-6067233D-C73B-4AEB-88C1-9A4EF52EDA43 @default.
- Q94147703 P356 Q94147703-05C59810-101F-4A73-872E-76B509FE1D25 @default.
- Q94147703 P433 Q94147703-F082B66E-464E-409F-870B-CA6C75C2083D @default.
- Q94147703 P478 Q94147703-D8B147AE-619E-47F3-A1F9-E710A3FEFD62 @default.
- Q94147703 P577 Q94147703-366DC09B-D990-4CBB-ACC1-6ED7B1045F5D @default.
- Q94147703 P921 Q94147703-1AE5C366-2646-4167-B2A1-E6B652FD852B @default.
- Q94147703 P932 Q94147703-68C7C796-FB11-4D53-808E-D0F92968FC71 @default.
- Q94147703 P356 NOY148.079 @default.
- Q94147703 P1433 Q15724471 @default.
- Q94147703 P1476 "ACTR-47. PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" @default.
- Q94147703 P2093 "Annemiek Walenkamp" @default.
- Q94147703 P2093 "Earle Bain" @default.
- Q94147703 P2093 "Enrico Franceschi" @default.
- Q94147703 P2093 "Iris de Heer" @default.